Entities

Company operating in Fintech.

Company operating in Biotech & Life Sciences.

Cybersecurity company.

Netdata operates in Data & Analytics.

A clinical-stage biopharmaceutical company developing precision medicines for neuropsychiatric, neurodegenerative and related brain diseases.

An enterprise AI orchestration platform for connecting, governing and managing multiple AI models and workloads.

Company operating in Cybersecurity.

An AI-native data security and data loss prevention platform for discovering, classifying and protecting sensitive information.

Electric vehicle startup founded in 2018 in Ann Arbor, Michigan, developing compact urban vehicles. A member of Y Combinator's Winter 2020 batch; YC currently lists the company as inactive. Distinct from the computational biotechnology company Nimbus Therapeutics.

Engineers soybeans to produce casein for animal-free cheese. Also known as Alpine Bio.

Norm Ai operates in Legal.

Company operating in Developer Tools.

Satellite ground-station network. Series A with Founders Fund. CEO Bridgit Mendler.

Company operating in Healthcare.

Nozomio Inc operates in AI.

A biotechnology company developing RNA medicines with an integrated, microfluidic manufacturing platform.

Company operating in Biotech & Life Sciences.

Opal operates in Cybersecurity.

Optimizely operates in Marketing & Advertising.

Pasadena company developing utility-scale, fault-tolerant quantum computers based on reconfigurable neutral atoms held in optical tweezers. Its architecture combines atomic physics, optical engineering, quantum algorithms and error correction, with AI systems used to automate research and hardware design. The company emerged publicly in March2026 following collaborative research with Caltech. The research proposes that cryptographically relevant quantum computation could require approximately10,000 atomic qubits; this is an architectural resource estimate, rather than a delivered commercial computer. Oratomic aims to build a fault-tolerant system by the end of the decade and is focusing on that objective rather than intermediate commercial products. Dolev Bluvstein is CEO and Manuel Endres is a co-founder. A USD300 million SeriesA announced July7,2026 was co-led by ARCH Venture Partners, Spark Capital and Khosla Ventures. A preceding December2025 seed was co-led by Formation VC and Nebular; its cash amount and exact announcement date remain undisclosed in the primary sources reviewed.

Orbital Inc. operates in Defense & Space.

Orchid Labs operates in Crypto & Web3.

64x operates in AI.

Orum operates in Fintech.

Oscar operates in Healthcare.

Pallet operates in HR & Talent.

Passport provides cities and operators with software for parking payments, permits, enforcement, and mobility management.

Gaming company.

Pelage Pharmaceuticals is developing PP405, a topical regenerative small molecule intended to reactivate dormant hair-follicle stem cells and restore hair growth.

Develops humanoid robots for physically demanding work in infrastructure and heavy industry.

Persona provides identity-verification and identity-management infrastructure that businesses configure for onboarding, fraud prevention, and compliance.

Defense & Space company.

Mobility & Transportation company.

Polars operates in Data & Analytics.

Presence operates in Education.

Prime Medicine develops prime-editing therapies designed to precisely correct disease-causing genetic mutations.

Logistics & Supply Chain company.

Prophet Security operates in Cybersecurity.

Pylon lets humans and AI agents collaborate on customer work, investigating, resolving, and acting on every signal. Trusted by 1,500+ B2B companies.

Infrastructure & Cloud company.

Company operating in Hardware & Semiconductors.

Quantum Circuits develops superconducting quantum computers based on dual-rail qubits with built-in error detection, pursuing fault-tolerant quantum computing.

RISC Zero operates in Cybersecurity.

Portable nuclear microreactors (Kaleidos). Founders Fund joined Series B and later rounds.

Radiant develops factory-built, transportable nuclear microreactors intended to replace diesel generators for defense, disaster response, remote industry and critical infrastructure.

Ramp is a financial operations platform combining corporate cards, expense management, bill payments, procurement, travel, banking and accounting automation.

Ramp Network operates in Fintech.

Rentomojo operates in Consumer.

Replimune is a biotechnology company developing oncolytic immunotherapies intended to destroy tumors locally and activate durable systemic anti-tumor immune responses.

Gaming company.

Company operating in PropTech.

Rightfoot operates in Fintech.

Healthcare company.

Rome operates in Developer Tools.

Gaming company.

AI fall detection for senior living. Founders Fund in $43M Series C.

Satomic developed software for managing and securing APIs and service-to-service communication in cloud-native environments.

Scale operates in AI.

Cybersecurity company.

Serán BioScience is a contract development and manufacturing organization providing formulation, analytical, clinical manufacturing, and commercial-scale services to drug developers.

SaaS company.

Shinkei Systems builds computer-vision and robotics systems that automate humane fish harvesting, improve freshness, and create traceable seafood supply chains.

Provides ecommerce fulfillment and logistics services, including warehousing, inventory management and shipping for online merchants.

ShipBob is a cloud-based logistics and fulfillment platform that helps e-commerce merchants store inventory, fulfill orders, and ship through a distributed warehouse network.

Shocking Technologies developed voltage-switchable dielectric nanocomposite materials embedded in electronics to protect circuits from electrostatic discharge.

ShopMy operates in E-Commerce & Marketplace.

Fintech company.

Silna Health operates in Healthcare.

Skip builds blockchain infrastructure and products for cross-chain interoperability, transaction ordering, and value capture in the Cosmos ecosystem.

Company operating in Logistics & Supply Chain.

Travel & Hospitality company.

Smallstep operates in Cybersecurity.

Smallstep provides automated certificate management and private certificate-authority infrastructure for securing people, devices, workloads, and services.

Sonoma Biotherapeutics operates in Biotech & Life Sciences.

Soundtrack Your brand operates in Media & Entertainment.

The AI sales assistant that eliminates CRM admin. Your CRM updates itself after every call, you get daily meeting briefs, and follow-ups write themselves. Save 9+ hours weekly.

Media & Entertainment company.

Berlin defence company (loitering munitions / Virtus). Sequoia and Founders Fund co-led ~€500M Series C June 2026.

Structify operates in AI.

SumUp provides payments and financial tools for small merchants, including card terminals, point-of-sale software, business accounts, invoicing and online-store products.

SumUp provides payments and financial tools for small merchants, including card terminals, point-of-sale software, business accounts, invoicing and online-store products.

Sun Day Carwash operates in Fintech.

Sundial Brands is a natural hair-care and skin-care manufacturer behind brands including SheaMoisture and Nubian Heritage; Unilever acquired the business in 2017.

Super operates in Consumer.

Superscale is an AI-native marketing operating system that helps brands and agencies research, create, analyze and iterate advertising across platforms such as Meta and Google.

Swan AI operates in Fintech.

Autonomous drone swarms for defence.

Preclinical RNAi biotechnology company developing conditionally activated siRNA therapeutics, initially focused on central nervous system diseases. Distinct from the Switch recruiting app.

Fintech company.

Syremis Therapeutics is a clinical-stage biopharmaceutical company developing neuropsychiatric medicines, including M1/M4 muscarinic agonists and next-generation NMDA antagonists.

Sysdig operates in Cybersecurity.

Fintech company.

TellApart built a data-driven advertising platform for retailers, including cross-device targeting and dynamic product ads; Twitter acquired the company in 2015.

Theai, Inc. is the legal entity operating as Inworld AI, which develops a real-time AI engine and runtime for interactive applications and games.

Trade Republic Bank GmbH is the legal entity behind Trade Republic, a European digital bank and brokerage offering investing, saving, cash and payment products.

AI software company developing governed, auditable agents for healthcare, government and enterprise deployments.

Company operating in SaaS.

Legal company.

VOI Technology operates in Mobility & Transportation.

Fintech company.

Washington, D.C. operational holding company for defense and government technology.

Valius Sciences operates in Biotech & Life Sciences.

Defense & Space company.

Company operating in Enterprise Software.

Company operating in Cybersecurity.

Vividion Therapeutics develops small-molecule medicines for difficult-to-drug targets using chemoproteomics and covalent drug-discovery technologies.

Vizgen develops spatial genomics tools, including the MERSCOPE platform, for high-resolution mapping of gene expression within tissues.

Volastra Therapeutics develops cancer therapies targeting chromosomal instability and related vulnerabilities in tumor biology.

WanderJaunt operated a technology-enabled short-term-rental management platform for booking and operating furnished homes.

Travel & Hospitality company.

African mobile money.

Commercial lease-to-own for SMBs.

Wonder operates in Food & Agriculture.

Crypto & Web3 company.

Xplenty was a cloud-based, low-code data integration platform for building ETL and reverse-ETL pipelines; it later became part of Integrate.io.

Indonesia

Roy has over 25 years of managerial experience in IT, building professional IT organizations in the government and private sectors, as well serving as Director of IT in successful startups such as Trianna, CommTouch and BRM .

Amir Zamani is publicly listed by Bain Capital Life Sciences as Partner. Previously a McKinsey healthcare partner and a physician in plastic surgery training.

Or is an 8200 alumni with a B.Sc.

Jeannette zu Fürstenberg is a founding partner of La Famiglia and a current published managing director of its La Famiglia II GmbH fund manager. General Catalyst’s own biography identifies her as President and Managing Director, responsible for Europe, with investment interests including AI, climate, industrial transformation and defence software. Her La Famiglia platform role and wider General Catalyst responsibility are distinct; existing outside affiliations and authentic portrait are preserved.

Jennie Daisak is publicly listed by Bain Capital Life Sciences as Vice President. Healthcare investment banking experience with J.P. Morgan.

Kristen Deftos is publicly listed by Bain Capital Life Sciences as Head of Human Resources, Double Impact, Life Sciences, Real Estate & Tech Opportunities. Leads talent acquisition and employee development across several Bain investment businesses.

Leonard Feiner, MD, PhD is publicly listed by Bain Capital Life Sciences as Principal. Former retinal surgeon and investigator in clinical trials for retinal diseases.

Melissa Danforth is publicly listed by Bain Capital Life Sciences as General Counsel, Life Sciences. Earlier private equity legal work at Ropes & Gray and public service with the U.S. government.

Evan Greif is publicly listed by Bain Capital Life Sciences as Principal. Earlier healthcare investing at Orbis Investments and consulting at Bain & Company.

Jonah Cashdan is publicly listed by Bain Capital Life Sciences as Principal. Healthcare investment banking at J.P. Morgan and neuroscience laboratory research.

Greg Koskinas is publicly listed by Bain Capital Life Sciences as Chief Financial Officer, Life Sciences. Leads life sciences finance; earlier operational and compliance responsibilities at ThornTree.

Sharad Goyal is publicly listed by Bain Capital Life Sciences as Head of IT, Private Markets. Manages shared private markets technology functions, following technology consulting at Sapient.

Linus Rehn, MD is publicly listed by Bain Capital Life Sciences as Associate. Trained as a physician; earlier healthcare consulting at McKinsey and immuno-oncology research.

Jay Corrigan is publicly listed by Bain Capital Life Sciences as Group Chief Financial Officer, Private Markets. Oversees shared private markets finance teams; previous experience at Ernst & Young.

Matthew Calistri is publicly listed by Bain Capital Life Sciences as Managing Director. Portfolio operations experience at Cerevel Therapeutics, Sage and Biogen.

Drew Field is publicly listed by Bain Capital Life Sciences as Principal. Healthcare strategy consulting at Bain & Company and commercial roles in biotechnology.

Shuvam Chaudhuri, PhD is publicly listed by Bain Capital Life Sciences as Vice President. Doctoral immunology research at Northwestern and antiviral discovery research at Janssen.

Renjie Wang is publicly listed by Bain Capital Life Sciences as Managing Director. Healthcare transaction experience at Hony Capital before joining Bain.

Lei Meng is publicly listed by Bain Capital Life Sciences as Managing Director. Therapeutics investing experience at Avidity Partners and pharmaceutical strategy roles.

Peter Raihelgauz serves as OurCrowd CFO.

Gabe Homa is OurCrowd’s Global Head of Investor Relations, responsible for all investor-facing activity across the platform.

Ricky Lijing Sun is publicly listed by Bain Capital Life Sciences as Partner. Previously worked in corporate strategy at Biogen, healthcare investing and pharmaceutical research.

Daniyal Sachee is publicly listed by Bain Capital Life Sciences as Associate. Healthcare financing experience at Goldman Sachs and research involving rare epilepsy disorders.